Fundraising FoxD2Discovery
1 known investors
Find your way into D2Discovery
Sign up to see every warm intro you have to D2Discovery
- Paths you didn't know you had: your email and LinkedIn already hold routes to the D2Discovery team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Data2Discovery builds a knowledge graph and data science software platform that integrates and analyzes large, complex, heterogeneous datasets to surface insights in fields such as drug discovery, disaster medicine, and food science. It serves pharmaceutical, biotech, research, and government organizations, with applications including drug repurposing, toxicology, and phenotypic analysis.
Founders & leadership
Investors · 1
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Science Foundation | Phase II | 2017 | $750K |
| National Science Foundation | Phase I | 2016 | $150K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does D2Discovery do?
- Data2Discovery builds a knowledge graph and data science software platform that integrates and analyzes large, complex, heterogeneous datasets to surface insights in fields such as drug discovery, disaster medicine, and food science. It serves pharmaceutical, biotech, research, and government organizations, with applications including drug repurposing, toxicology, and phenotypic analysis.
- Who founded D2Discovery?
- D2Discovery was founded by David Wild.
- Who are D2Discovery's investors?
- D2Discovery's investors include IU Ventures.